KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Publisher
Elsevier BV
Subject
Cell Biology
Reference55 articles.
1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016
2. Endocrine-responsive breast cancer and strategies for combating resistance;Ali;Nat. Rev. Cancer,2002
3. Cellular and molecular pharmacology of antiestrogen action and resistance;Clarke;Pharmacol. Rev.,2001
4. Endocrine resistance in breast cancer: current status and a perspective on the roles of miRNAs (review);Zhou;Oncol. Lett.,2013
5. Factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression;Zhang;J. Biol. Chem.,2010
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dexamethasone–tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells;Bioscience Reports;2024-07
2. Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives;Cell Cycle;2024-03-18
3. CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model;Aging;2023-10-19
4. Evaluation of KLF4 Gene and Long Non-coding RNA MIR503HG Expression in Breast Cancer Patients in Iran;2023-08-27
5. Evaluation of KLF4 Gene and Long Non-coding RNA MIR503HG Expression in Breast Cancer Patients in Iran;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3